Free Trial
OTCMKTS:BTCY

Biotricity (BTCY) Stock Price, News & Analysis

Biotricity logo
$0.51 +0.00 (+0.76%)
As of 05/12/2025 03:32 PM Eastern

About Biotricity Stock (OTCMKTS:BTCY)

Key Stats

Today's Range
$0.47
$0.58
50-Day Range
$0.31
$0.55
52-Week Range
$0.19
$1.30
Volume
24,571 shs
Average Volume
37,276 shs
Market Capitalization
$12.80 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Biotricity, Inc., a medical technology company, provides biometric data monitoring solutions in the United States. The company focuses on delivery of remote monitoring solutions to medical, healthcare, and consumer markets, including diagnostic and post-diagnostic solutions for lifestyle and chronic illnesses. It offers Bioflux mobile cardiac telemetry solution, an integrated ECG device; and ECG analysis software that analyzes and synthesizes patient ECG monitoring data, as well as software components. The company is based in Redwood City, California.

Receive BTCY Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Biotricity and its competitors with MarketBeat's FREE daily newsletter.

BTCY Stock News Headlines

H.C. Wainwright Sticks to Their Hold Rating for Biotricity (BTCY)
Biotricity expands IP portfolio with 14 new patents
Here’s How to Claim Your Stake in Elon’s Private Company, xAI
I predict this single breakthrough could make Elon the world’s first trillionaire — and mint more new millionaires than any tech advance in history. And for a limited time, you have the chance to claim a stake in this project, even though it’s housed inside Elon’s private company, xAI.
Biotricity reports Q3 EPS (5c) vs. (34c) last year
See More Headlines

BTCY Stock Analysis - Frequently Asked Questions

Biotricity's stock was trading at $0.2899 at the beginning of the year. Since then, BTCY shares have increased by 77.3% and is now trading at $0.5139.
View the best growth stocks for 2025 here
.

Biotricity, Inc. (OTCMKTS:BTCY) released its earnings results on Wednesday, February, 19th. The company reported ($0.05) earnings per share for the quarter, topping the consensus estimate of ($0.11) by $0.06. The company earned $3.62 million during the quarter, compared to the consensus estimate of $3.30 million.
Read the conference call transcript
.

Biotricity shares reverse split on Monday, July 3rd 2023. The 1-6 reverse split was announced on Monday, July 3rd 2023. The number of shares owned by shareholders was adjusted after the market closes on Monday, July 3rd 2023. An investor that had 100 shares of stock prior to the reverse split would have 17 shares after the split.

Shares of BTCY stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Biotricity investors own include NVIDIA (NVDA), Meta Platforms (META), Tesla (TSLA), Advanced Micro Devices (AMD), Broadcom (AVGO), Micron Technology (MU) and Bank of America (BAC).

Company Calendar

Last Earnings
2/19/2025
Today
5/12/2025
Fiscal Year End
3/31/2026

Industry, Sector and Symbol

Stock Exchange
OTCMKTS
Sector
Medical
Industry
Medical Devices
Sub-Industry
Medical Equipment
Current Symbol
OTCMKTS:BTCY
Fax
N/A
Employees
40
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
$-18,660,000.00
Net Margins
-163.11%
Pretax Margin
-163.11%

Debt

Sales & Book Value

Annual Sales
$12.06 million
Price / Cash Flow
N/A
Book Value
($2.67) per share
Price / Book
-0.19

Miscellaneous

Free Float
6,963,000
Market Cap
$12.80 million
Optionable
Not Optionable
Beta
1.22
Beginner's Guide To Retirement Stocks Cover

Enter your email address and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.

Get This Free Report

This page (OTCMKTS:BTCY) was last updated on 5/13/2025 by MarketBeat.com Staff
From Our Partners